73 related articles for article (PubMed ID: 23424127)
1. Systematic identification of risk factors for Alzheimer's disease through shared genetic architecture and electronic medical records.
Li L; Ruau D; Chen R; Weber S; Butte AJ
Pac Symp Biocomput; 2013; ():224-35. PubMed ID: 23424127
[TBL] [Abstract][Full Text] [Related]
2. Blood clusterin levels, rs9331888 polymorphism, and the risk of Alzheimer's disease.
Xing YY; Yu JT; Cui WZ; Zhong XL; Wu ZC; Zhang Q; Tan L
J Alzheimers Dis; 2012; 29(3):515-9. PubMed ID: 22258514
[TBL] [Abstract][Full Text] [Related]
3. Translating genome wide association study results to associations among common diseases: in silico study with an electronic medical record.
Anand V; Rosenman MB; Downs SM
Int J Med Inform; 2013 Sep; 82(9):864-74. PubMed ID: 23743324
[TBL] [Abstract][Full Text] [Related]
4. D10S1423 identifies a susceptibility locus for Alzheimer's disease in a prospective, longitudinal, double-blind study of asymptomatic individuals.
Zubenko GS; Hughes HB; Stiffler JS
Mol Psychiatry; 2001 Jul; 6(4):413-9. PubMed ID: 11443525
[TBL] [Abstract][Full Text] [Related]
5. Lessons from genome-wide association studies findings in Alzheimer's disease.
Moraes CF; Lins TC; Carmargos EF; Naves JO; Pereira RW; Nóbrega OT
Psychogeriatrics; 2012 Mar; 12(1):62-73. PubMed ID: 22416831
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
Cacabelos R
Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
[TBL] [Abstract][Full Text] [Related]
7. Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysis.
Lambert JC; Grenier-Boley B; Chouraki V; Heath S; Zelenika D; Fievet N; Hannequin D; Pasquier F; Hanon O; Brice A; Epelbaum J; Berr C; Dartigues JF; Tzourio C; Campion D; Lathrop M; Amouyel P
J Alzheimers Dis; 2010; 20(4):1107-18. PubMed ID: 20413860
[TBL] [Abstract][Full Text] [Related]
8. Cell adhesion molecules contribute to Alzheimer's disease: multiple pathway analyses of two genome-wide association studies.
Liu G; Jiang Y; Wang P; Feng R; Jiang N; Chen X; Song H; Chen Z
J Neurochem; 2012 Jan; 120(1):190-8. PubMed ID: 22017384
[TBL] [Abstract][Full Text] [Related]
9. BDNF genetic variations increase the risk of Alzheimer's disease-related depression.
Borroni B; Grassi M; Archetti S; Costanzi C; Bianchi M; Caimi L; Caltagirone C; Di Luca M; Padovani A
J Alzheimers Dis; 2009; 18(4):867-75. PubMed ID: 19661618
[TBL] [Abstract][Full Text] [Related]
10. GSTO1*E155del polymorphism associated with increased risk for late-onset Alzheimer's disease: association hypothesis for an uncommon genetic variant.
Piacentini S; Polimanti R; Squitti R; Mariani S; Migliore S; Vernieri F; Rossini PM; Manfellotto D; Fuciarelli M
Neurosci Lett; 2012 Jan; 506(2):203-7. PubMed ID: 22100662
[TBL] [Abstract][Full Text] [Related]
11. Joint association discovery and diagnosis of Alzheimer's disease by supervised heterogeneous multiview learning.
Zhe S; Xu Z; Qi Y; Yu P;
Pac Symp Biocomput; 2014; ():300-11. PubMed ID: 24297556
[TBL] [Abstract][Full Text] [Related]
12. PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
Belbin O; Beaumont H; Warden D; Smith AD; Kalsheker N; Morgan K
Neurobiol Aging; 2009 Dec; 30(12):1992-9. PubMed ID: 18403054
[TBL] [Abstract][Full Text] [Related]
13. Examination of the current top candidate genes for AD in a genome-wide association study.
Feulner TM; Laws SM; Friedrich P; Wagenpfeil S; Wurst SH; Riehle C; Kuhn KA; Krawczak M; Schreiber S; Nikolaus S; Förstl H; Kurz A; Riemenschneider M
Mol Psychiatry; 2010 Jul; 15(7):756-66. PubMed ID: 19125160
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease genes and cognition in the nondemented general population.
Verhaaren BF; Vernooij MW; Koudstaal PJ; Uitterlinden AG; van Duijn CM; Hofman A; Breteler MM; Ikram MA
Biol Psychiatry; 2013 Mar; 73(5):429-34. PubMed ID: 22592056
[TBL] [Abstract][Full Text] [Related]
15. Association study and meta-analysis of Alzheimer's disease risk and presenilin-1 intronic polymorphism.
Rodríguez-Manotas M; Amorín-Díaz M; Cañizares-Hernández F; Ruíz-Espejo F; Martínez-Vidal S; González-Sarmiento R; Martínez-Hernández P; Cabezas-Herrera J
Brain Res; 2007 Sep; 1170():119-28. PubMed ID: 17719017
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin D gene and the risk of Alzheimer's disease: a population-based study and meta-analysis.
Schuur M; Ikram MA; van Swieten JC; Isaacs A; Vergeer-Drop JM; Hofman A; Oostra BA; Breteler MM; van Duijn CM
Neurobiol Aging; 2011 Sep; 32(9):1607-14. PubMed ID: 19926167
[TBL] [Abstract][Full Text] [Related]
17. Study of thyroid hormone receptor alpha gene polymorphisms on Alzheimer's disease.
Goumidi L; Flamant F; Lendon C; Galimberti D; Pasquier F; Scarpini E; Hannequin D; Campion D; Amouyel P; Lambert JC; Meirhaeghe A
Neurobiol Aging; 2011 Apr; 32(4):624-30. PubMed ID: 19427062
[TBL] [Abstract][Full Text] [Related]
18. An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease.
Lescai F; Chiamenti AM; Codemo A; Pirazzini C; D'Agostino G; Ruaro C; Ghidoni R; Benussi L; Galimberti D; Esposito F; Marchegiani F; Cardelli M; Olivieri F; Nacmias B; Sorbi S; Tagliavini F; Albani D; Martinelli Boneschi F; Binetti G; Santoro A; Forloni G; Scarpini E; Crepaldi G; Gabelli C; Franceschi C
J Alzheimers Dis; 2011; 24(2):235-45. PubMed ID: 21263195
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics in Alzheimer's disease.
Cacabelos R
Methods Mol Biol; 2008; 448():213-357. PubMed ID: 18370236
[TBL] [Abstract][Full Text] [Related]
20. Involvement of paraoxonase 1 genetic variants in Alzheimer's disease neuropathology.
Leduc V; Théroux L; Dea D; Robitaille Y; Poirier J
Eur J Neurosci; 2009 Nov; 30(9):1823-30. PubMed ID: 19863653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
